HCA Healthcare EVP & Chief Clinical Officer appointment; Dr. Perlin to depart March 2022

HCA Healthcare, Inc.

Dr. Jonathan B. Perlin will depart as President-Clinical Ops and CMO to become CEO of The Joint Commission, effective March 1, 2022.
Dr. Perlin remains in current role through Dec 31, 2021; transition period from Jan 1 to Feb 28, 2022.
Effective Jan 1, 2022, Dr. Michael S. Cuffe named Executive Vice President and Chief Clinical Officer.
Board approved the changes at October 21, 2021 meeting; orderly succession for a key clinical leadership role.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jonathan B. Perlin

President - Clinical Operations Group and Chief Medical Officer

HCA · HCA Healthcare, Inc.

Effective: 2022-03-01
Successor: Michael S. Cuffe
Filed: October 27, 2021, 7:59 PM ET

Dr. Jonathan B. Perlin, President - Clinical Operations Group and Chief Medical Officer, notified HCA Healthcare, Inc. (the “Company”) on September 16, 2021 that he had accepted the role of president and CEO of The Joint Commission and will assume his new role on March 1, 2022.

Appointed

Michael S. Cuffe

Executive Vice President and Chief Clinical Officer

HCA · HCA Healthcare, Inc.

Effective: 2022-01-01
Filed: October 27, 2021, 7:59 PM ET

effective January 1, 2022, Dr. Michael S. Cuffe will become Executive Vice President and Chief Clinical Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan B. Perlin departed as President - Clinical Operations Group and Chief Medical Officer at HCA Healthcare, Inc..

Action: notified
Role: President - Clinical Operations Group and Chief Medical Officer

Exact text from the filing

Dr. Jonathan B. Perlin, President - Clinical Operations Group and Chief Medical Officer, notified HCA Healthcare, Inc. (the “Company”) on September 16, 2021 that he had accepted the role of president and CEO of The Joint Commission and will assume his new role on March 1, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael S. Cuffe was appointed as Executive Vice President and Chief Clinical Officer at HCA Healthcare, Inc..

Action: appointed
Role: Executive Vice President and Chief Clinical Officer

Exact text from the filing

effective January 1, 2022, Dr. Michael S. Cuffe will become Executive Vice President and Chief Clinical Officer.

View on SEC.gov

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-309426

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.